Legal Consultations

General Guideline on Regulatory and Scientific Requirements for Development and Approval of Biosimilars

Activity start
10/11/2025
Activity end
09/01/2026
3
Results announcement
Not Specified
The guideline provides an overview of the biosimilar protocol, reference product selection, the concept of the biosimilar comparison process, and the general regulatory and scientific requirements for the development and approval of biosimilars.
Close
Total number of comments on this page  0  comments

Me ?

This information is requested for national analytical purposes to improve the unified national platform and to verify the gender satisfaction/dissatisfaction ratio.

Invalid Captcha Code
Success
Your feedback has been successfully received. Thank you for your contribution to the platform's development.
% of users said yes from comments

Date of last update of page content: 12/03/2026at the hour 11:47 Saudi Arabia time